Fifth Third Bancorp Has $3.09 Million Holdings in Agilent Technologies, Inc. (NYSE:A)

Fifth Third Bancorp lessened its holdings in Agilent Technologies, Inc. (NYSE:A) by 19.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 26,428 shares of the medical research company’s stock after selling 6,362 shares during the quarter. Fifth Third Bancorp’s holdings in Agilent Technologies were worth $3,092,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of A. Flynn Zito Capital Management LLC lifted its position in Agilent Technologies by 3.8% during the 4th quarter. Flynn Zito Capital Management LLC now owns 1,871 shares of the medical research company’s stock valued at $251,000 after purchasing an additional 69 shares during the period. IFP Advisors Inc lifted its position in Agilent Technologies by 17.7% during the 4th quarter. IFP Advisors Inc now owns 458 shares of the medical research company’s stock valued at $62,000 after purchasing an additional 69 shares during the period. Tiemann Investment Advisors LLC lifted its position in Agilent Technologies by 5.6% during the 4th quarter. Tiemann Investment Advisors LLC now owns 1,423 shares of the medical research company’s stock valued at $191,000 after purchasing an additional 75 shares during the period. Rothschild Investment LLC lifted its position in Agilent Technologies by 19.2% during the 4th quarter. Rothschild Investment LLC now owns 491 shares of the medical research company’s stock valued at $66,000 after purchasing an additional 79 shares during the period. Finally, CIBC Private Wealth Group LLC lifted its position in Agilent Technologies by 1.2% during the 4th quarter. CIBC Private Wealth Group LLC now owns 7,479 shares of the medical research company’s stock valued at $1,025,000 after purchasing an additional 87 shares during the period.

Insider Activity at Agilent Technologies

In other Agilent Technologies news, VP Rodney Gonsalves sold 1,908 shares of the firm’s stock in a transaction on Monday, March 17th. The stock was sold at an average price of $121.98, for a total transaction of $232,737.84. Following the completion of the sale, the vice president now owns 21,786 shares of the company’s stock, valued at $2,657,456.28. This trade represents a 8.05% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Daniel K. Podolsky sold 1,819 shares of the firm’s stock in a transaction on Monday, March 31st. The shares were sold at an average price of $116.46, for a total value of $211,840.74. Following the sale, the director now directly owns 35,737 shares of the company’s stock, valued at $4,161,931.02. This represents a 4.84% decrease in their position. The disclosure for this sale can be found here.

Agilent Technologies Price Performance

Shares of A opened at $116.97 on Friday. The stock has a market capitalization of $33.23 billion, a P/E ratio of 28.88, a P/E/G ratio of 3.61 and a beta of 1.23. Agilent Technologies, Inc. has a twelve month low of $96.43 and a twelve month high of $153.84. The company has a 50 day moving average of $109.34 and a 200-day moving average of $125.38. The company has a quick ratio of 1.60, a current ratio of 2.09 and a debt-to-equity ratio of 0.55.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, May 28th. The medical research company reported $1.31 earnings per share for the quarter, topping the consensus estimate of $1.26 by $0.05. The company had revenue of $1.67 billion during the quarter, compared to analysts’ expectations of $1.63 billion. Agilent Technologies had a net margin of 17.59% and a return on equity of 25.92%. The business’s quarterly revenue was up 6.0% on a year-over-year basis. During the same period last year, the business earned $1.22 EPS. As a group, equities research analysts forecast that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 23rd. Investors of record on Tuesday, July 1st will be paid a $0.248 dividend. The ex-dividend date of this dividend is Tuesday, July 1st. This represents a $0.99 annualized dividend and a dividend yield of 0.85%. Agilent Technologies’s dividend payout ratio is presently 24.44%.

Wall Street Analyst Weigh In

A has been the topic of a number of analyst reports. UBS Group cut their price target on shares of Agilent Technologies from $150.00 to $130.00 and set a “neutral” rating on the stock in a research report on Thursday, May 29th. Wells Fargo & Company cut their price target on shares of Agilent Technologies from $155.00 to $135.00 and set an “overweight” rating on the stock in a research report on Thursday, April 17th. Wall Street Zen downgraded shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research report on Saturday. TD Cowen increased their price target on shares of Agilent Technologies to $150.00 and gave the company a “buy” rating in a research report on Thursday, May 29th. Finally, Leerink Partners increased their price target on shares of Agilent Technologies to $135.00 and gave the company a “buy” rating in a research report on Friday, May 30th. Eight analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat.com, Agilent Technologies has a consensus rating of “Hold” and a consensus target price of $140.15.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.